AI accelerates biomanufacturing’s reliance on synthetic phage ecosystems—exposing ecological and ethical trade-offs in industrial virology

Indigenous knowledge systems view viruses as integral to ecological balance, with practices like the use of phage-rich soils in agriculture reflecting a deep understanding of microbial networks. The industrial framing of viruses as 'tools' for biomanufacturing contradicts this holistic perspective, reducing complex ecological relationships to extractable resources. Traditional ecological knowledge could offer alternatives to synthetic phage ecosystems, such as using native phage communities to control pathogens without disrupting microbial diversity.

The history of phage therapy in medicine reveals a pattern of initial promise followed by setbacks due to bacterial resistance and industrial oversimplification of microbial ecosystems. The early 20th-century use of phages in agriculture and medicine demonstrates how narrow, industrial applications of viral ecosystems can lead to unintended consequences, such as the rise of resistant bacterial strains. This historical precedent raises concerns about the long-term viability of AI-driven phage tracking in biomanufacturing.

Cross-culturally, viruses are not universally viewed as adversaries; in many indigenous cosmologies, they are seen as teachers or regulators of life, with roles in healing and ecological balance. The Western biomedical model, which frames viruses as targets for elimination, contrasts sharply with these perspectives, leading to a disconnect between industrial virology and holistic health systems. This cultural divide is exacerbated by the commodification of viral lifeforms, which prioritizes profit over traditional ecological wisdom.

Scientifically, the use of AI to track and engineer phages for biomanufacturing is grounded in advances in metagenomics and machine learning, but it lacks long-term ecological impact assessments. The methodology risks oversimplifying the complexity of phage-bacteria interactions, which are influenced by environmental factors and microbial diversity. Additionally, the reliance on synthetic phage ecosystems could accelerate the evolution of resistant bacterial strains, undermining the very systems they aim to enhance.

Artistically and spiritually, viruses have been depicted as both destroyers and creators in human culture, from the Hindu god Shiva's association with destruction and regeneration to the biblical plagues. The industrial framing of viruses as 'good' or 'bad' based on utility reflects a mechanistic worldview that contrasts with spiritual traditions emphasizing balance and interconnectedness. This duality is mirrored in the tension between the commodification of viral life and the sacredness of life in many indigenous traditions.

Future modelling suggests that the unchecked expansion of AI-driven phage ecosystems could lead to ecological tipping points, where engineered phages disrupt natural microbial networks and trigger cascading effects on biodiversity. Scenario planning must account for the potential for horizontal gene transfer between engineered and wild phages, which could create novel pathogens or disrupt existing ecological balances. Additionally, the economic and ethical implications of viral commodification—such as biopiracy and the erosion of traditional knowledge—must be integrated into long-term risk assessments.

Marginalized communities, particularly in biodiversity-rich regions of the Global South, are often excluded from decisions about the use of their local viral ecosystems, despite bearing the ecological and health risks of industrial exploitation. Indigenous scientists and local communities have raised concerns about the ethical implications of patenting viral strains, which they argue is a form of biopiracy. The lack of representation of these voices in the narrative reinforces power imbalances and obscures the true costs of industrial virology.